Skip to content
DataLookout
Menu

ReLapsNCT07178925

Follow-up Cohort of Patients With Antiphospholipid Syndrome

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Oct 16, 2026 to Oct 16, 2027
    • Eligibility criteria expanded, about 4 words
    • Study completion pushed from Oct 16, 2031 to Oct 16, 2032
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Thrombotic recurrence rate
Timeframe: Patients will be followed up in consultation every 3 months, 6 months to 1 year, for 5 years, depending on the situation. Follow-ups will not be modified compared to the usual management of the disease.

Secondary (4)

Complication rate
Risk factors associated
Mortality rates
Morbidity rates

Arms and interventions

Other: Study of Antiphospholipid Syndrome responding to the Sydney classification of 2006

Sites

1 site in 1 country

  • University hospital of RouenRouen, France